Pujol, FR
Alexandre Pujol, Ste Foy D'Aigrefeuille FR
Patent application number | Description | Published |
---|---|---|
20150160668 | VOLTAGE RECULATOR CIRCUIT AND METHOD THEREFOR - A voltage regulator circuit arranged to receive a voltage supply signal, and to output a regulated voltage signal is described. The voltage regulator circuit comprises at least one switched mode power supply component selectively configurable to perform regulation of the voltage supply signal, at least one linear voltage regulator component selectively configurable to perform regulation of the voltage supply signal, and at least one controller component. The at least one controller component is arranged to receive an indication of a voltage level of the voltage supply signal, and configure a bulk connection for at least one switching device of the at least one linear voltage regulator component such that current flow from an output of the voltage regulator circuit to an input of the voltage regulator circuit through the bulk of the at least one switching device of the at least one linear voltage regulator component is resisted, if the indicated voltage level of the voltage supply signal is less than the threshold voltage level. | 06-11-2015 |
20150177755 | LINEAR VOLTAGE REGULATOR DEVICE AND ELECTRONIC DEVICE - The present invention pertains to a linear power regulator device, comprising an internal pass device, a driver device having a driver output arranged to drive the internal pass device via the driver output, wherein the linear power regulator device comprises an external connection connectable or connected to an external pass device; and wherein the driver device is arranged to drive an external pass device via the driver output and the external connection. The invention also pertains to a corresponding electronic device. | 06-25-2015 |
20150212531 | LINEAR POWER REGULATOR DEVICE AND ELECTRONIC DEVICE - The present invention pertains to a linear power regulator device that includes an internal pass device, a driver device having a driver output arranged to drive the internal pass device via the driver output. The linear power regulator device also includes an external connection connectable or connected to an external pass device; and the driver device is arranged to drive the external pass device via the driver output and the external connection. | 07-30-2015 |
Alexandre Pujol, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20090302950 | SINGLE INPUT DUAL OUTPUT VOLTAGE POWER SUPPLY AND METHOD THEREFOR - In one embodiment, a power supply controller is configured to form both positive and negative supply voltages from a single input voltage so the maximum differential voltage across a load that uses the positive and negative supply voltages is no greater than the maximum value of the input voltage | 12-10-2009 |
20100141342 | AMPLIFICATION CIRCUIT AND METHOD THEREFOR - In one embodiment, an amplification circuit charges a filter capacitor ( | 06-10-2010 |
Anais Pujol, Andernos Les Bains FR
Patent application number | Description | Published |
---|---|---|
20100234338 | CHELATING AGENTS OF METAL IONS, THEIR METHODS OF PREPARATION AND THEIR APPLICATIONS - The present invention relates to compounds that can be used as metal-ion-chelating agents or as depolluting agents, corresponding to general formula (I) below: | 09-16-2010 |
20130251639 | Novel Cyclodecapeptide Compounds For Use As Drugs - The invention relates to novel cyclodecapeptide compounds having formula (I) for use as drugs and, more specifically, for use in the diagnosis, prevention and/or treatment of neurodegenerative diseases, such as Wilson's disease and Alzheimer's disease, and for use in the diagnosis, prevention and/or treatment of poisoning with metal ions, such as copper and mercury ions. The invention also relates to pharmaceutical compositions comprising at least one compound having formula (I) as an active principle. | 09-26-2013 |
Anaïs Pujol, Andernos Les Bains FR
Patent application number | Description | Published |
---|---|---|
20130251639 | Novel Cyclodecapeptide Compounds For Use As Drugs - The invention relates to novel cyclodecapeptide compounds having formula (I) for use as drugs and, more specifically, for use in the diagnosis, prevention and/or treatment of neurodegenerative diseases, such as Wilson's disease and Alzheimer's disease, and for use in the diagnosis, prevention and/or treatment of poisoning with metal ions, such as copper and mercury ions. The invention also relates to pharmaceutical compositions comprising at least one compound having formula (I) as an active principle. | 09-26-2013 |
Claude Pujol, Rueil Malmaison FR
Patent application number | Description | Published |
---|---|---|
20080282614 | Vehicle Door Provided with a Joint - The invention relates to a railway vehicle including a body defining a wall in which an access passage is embodied, at least one closing sliding door, a sealing joint carried by the door and applicable to the wall when said door in a closed position. Said wall includes a panel provided with a generally cylindrical envelop and a seat which is protruded with respect to said panel and defines a bearing surface for supporting the joint only when the door is in the closed position, wherein said bearing surface of a supporting element extends along a profile substantially identical to the joint profile and said joint profile extends transversely with respect to the door displacement direction. | 11-20-2008 |
20090090266 | RAILWAY VEHICLE AND DEVICE FOR ACCESSING SAID VEHICLE - Railway vehicle ( | 04-09-2009 |
Florian Pujol, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20120103831 | METHOD FOR MEMBRANE PERMEABILIZATION OF BIOLOGICAL CELLS BY USING A PULSED ELECTRIC FIELD - A method for membrane permeabilization of biological cells contained in a product is disclosed. According to one aspect, the method is applied in a treatment device including at least one treatment chamber emitting a pulsed electric field. According to another aspect, the method includes supplying the treatment device with a product including biological cells at a predetermined supply flow rate from a supply unit, introducing the product including the biological cells into the treatment chamber at an introduction flow rate, treating the product introduced into the chamber with a pulsed electric field, and reintroducing the treated product, at a predetermined feedback flow rate at a point that is downstream from the supply unit. According to some aspects, the introduction flow rate includes the feedback flow rate and the supply flow rate. | 05-03-2012 |
Jean-Francois Pujol, Paris FR
Patent application number | Description | Published |
---|---|---|
20090258883 | 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds - Compounds of formula (I): | 10-15-2009 |
20130178493 | USE OF 14,15-DIHYDRO-20,21-DINOREBURNAMENIN-14-OL FOR THE TREATMENT AND/OR PREVENTION OF SERIOUS DEPRESSION AND SLEEP/WAKING CYCLE DISORDERS - The invention relates to a novel therapeutic use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment of serious depression in humans, particularly for the treatment of a patients resistant to conventional anti-depressant treatments and for treatment of sleep/waking cycle disorders. | 07-11-2013 |
20150056622 | EDITING PROFILING OF PDE8A PRE -MRNA: USE AS SPECIFIC BIOMARKER OF ADARS ACTIVITIES IN HUMAN TISSUES TO DIAGNOSE AND TO PREDICT AND ASSESS THERAPEUTIC EFFICACY AND/OR EFFICIENCY OR POTENTIAL DRUG SIDE EFFECTS - The present invention relates to the use of the editing profile of PDE8A pre-mRNA as a specific bio marker of ADARs activities in evolved primate, particularly in Human tissues. The present invention also relates to an in vitro method for predicting in Human an alteration of the mechanism of the ADARs catalysed pre-mRNA editing of target genes, by analysing the PDE8A pre-mRNA editing profile in a peripheral tissue sample containing cells expressing said PDE8A pre-mRNA, such as blood sample. The present invention is also directed to an in vitro method for the screening of potential therapeutic compound and to predict and assess therapeutic efficacy and/or efficiency or to diagnose potential severe brain or peripheral drug side effects implementing said PDE8A pre-mRNA editing profile as specific biomarker. The present invention is further directed to a method for determining the PDE8A pre-mRNA editing profile in Human, particularly by capillary electrophoresis single-strand conformation polymorphism (CE-SSCP) method after amplification by a nested PCR. Finally the invention relates to particular nucleic acid primers implemented in said nested PCR and kit comprising such sets of primers and human cells capable of expressing PDE8A and ADARs. | 02-26-2015 |
Jean-François Pujol, Paris FR
Patent application number | Description | Published |
---|---|---|
20110201636 | USE OF 14,15-DIHYDRO-20,21-DINOREBURNAMENIN-14-OL FOR THE TREATMENT AND/OR PREVENTION OF SERIOUS DEPRESSION AND SLEEP/WAKING CYCLE DISORDERS - The invention relates to a novel therapeutic use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment of serious depression in humans, particularly for the treatment of a patients resistant to conventional anti-depressant treatments and for treatment of sleep/waking cycle disorders. | 08-18-2011 |
Jean-Marc Pujol, Rilleux FR
Patent application number | Description | Published |
---|---|---|
20090035655 | Crosslinkable composition for a battery electrolyte - The field of the present invention relates to the field of batteries and of polymer electrolytes for batteries and more particularly to the field of lithium batteries. | 02-05-2009 |
Jean-Pierre Pujol, Douvres-La-Delivrande FR
Patent application number | Description | Published |
---|---|---|
20090175965 | USE OF UNSAPONIFIABLE COMPONENTS OF VEGETABLE OILS FOR PREPARING A COSMETIC AND RELATED TREATMENTS - The invention relates to the use of at least one unsaponifiable component of vegetable oil, in particular of avocado, soya bean and/or lupin oils, for the preparation of a medicament intended to stimulate the expression of TGF-β or the expression of the plasminogen activator inhibitor PAI-1. | 07-09-2009 |
Olivier Pujol, Villeneuve D,ascq FR
Patent application number | Description | Published |
---|---|---|
20100164786 | Method of Characterizing the Convection Intensity of a Cloud, by a Meteorological Radar - The present invention relates to a method of characterizing the convection intensity of a cloud by a meteorological radar. | 07-01-2010 |
20120133551 | METHOD OF CORRECTING REFLECTIVITY MEASUREMENTS AND RADAR IMPLEMENTING THIS METHOD - A method of correcting reflectivity measurements performed by a radar, such as a weather radar, includes a reflectivity measurement being associated with a resolution volume. The method includes acquiring the reflectivity measurement Z | 05-31-2012 |
20120139779 | METHOD OF CORRECTING REFLECTIVITY MEASUREMENTS BY ISOTHERM DETECTION AND RADAR IMPLEMENTING THE METHOD - A method of correcting the reflectivity measurements performed by a radar such as a weather radar, a reflectivity measurement being associated with a resolution volume includes analyzing the current resolution volume to determine whether the plane representing the 0° C. isotherm passes through it. When the plane representing the 0° C. isotherm passes through the current resolution volume, the volume is split into two parts lying on either side of said plane, the attenuation associated with the resolution volume is determined by taking into account the contribution of each of the parts to the measured reflectivity. The reflectivity associated with the current resolution volume is corrected using the attenuation thus determined. An onboard weather radar implements the method. | 06-07-2012 |
Olivier Pujol, Montaigut Sur Save FR
Patent application number | Description | Published |
---|---|---|
20100090829 | METHOD FOR MONITORING AUTHORIZED AND UNAUTHORIZED PERSONS WITHIN A SECURITY PERIMETER AROUND AN APPARATUS - The invention relates to the automatic detection of the presence of non-authorized persons in the vicinity of an apparatus of the aircraft type. To this end, the invention comprises equipping persons with radio transmitters for identifying them as authorized personnel. The aircraft are also fitted, such as at the existing PODs, with a transceiver device of a radio identification system of the RFID type for recognition of the persons wearing the radio transmitters. Only the persons who are not authorized in the vicinity of the aircraft initiate an alarm procedure. | 04-15-2010 |
20100201517 | DEVICE AND METHOD FOR PROTECTION AGAINST INTRUSION INTO THE LANDING GEAR HOUSING OF AIRCRAFT - The invention relates to a device for protection against intrusions into the landing gear housings of an aircraft, including at least one sensor, for at least one housing, covering at least one housing entry area and connected to a calculator ( | 08-12-2010 |
20110273269 | METHOD FOR MONITORING AND LOCKING AIRCRAFT COMPARTMENT DOORS - The invention relates to a system for monitoring and locking aircraft compartment doors ( | 11-10-2011 |
20120211601 | AIRCRAFT NOSE SECTION INCLUDING A LOCK FOR ACCESSING THE COCKPIT - An aircraft fuselage nose section having a secure access between the cockpit and the passenger cabin, while being compact. For that purpose, the nose section includes a separating mechanism including at least one movable element slidingly movable between: an extended closing position at which the separating mechanism bounds, with the cockpit door, a transition zone between the cockpit and the passenger cabin, and prevents people from passing between the passenger cabin and the transition zone; and a retracted opening position wherein the separating mechanism allows people to pass between the passenger cabin and the transition zone. | 08-23-2012 |
Olivier Pujol, Beauzelle FR
Patent application number | Description | Published |
---|---|---|
20100140407 | LOCKING AND UNLOCKING SYSTEM FOR THE COCKPIT DOOR OF AN AIRCRAFT AND DOOR WITH SUCH A SYSTEM - Embodiments relate to a locking and unlocking system of a separation door separating a cockpit from a cabin of an aircraft. In one embodiment, a system comprises a set of electrically controlled bolts configured to lock the door, a control unit configured to electrically control the set of bolts, a first manual control connected to the control unit, installed in the cockpit and configured to unlock the door, a second manual control connected to the control unit, installed in the cabin and configured to unlock the door, an accelerometer to detect a crash, and a switching relay to control automatic unlocking of the door when a crash of the aircraft is detected, the relay connected to the accelerometer, the control unit and the set of bolts. | 06-10-2010 |
Rémi Pujol, Feytiat FR
Patent application number | Description | Published |
---|---|---|
20150292436 | LOCKING/UNLOCKING DEVICE FOR A ONE-PIECE COWL OF A THRUST REVERSER OF A TURBOJET ENGINE NACELLE - An assembly for a turbojet engine includes a pylon, a nacelle supported by the pylon, and a locking device interposed between the pylon and a cowl of the nacelle. The cowl slides between operating and maintenance positions. The locking device is movable between active and inhibited positions, and the device allows an operation mode in the active position and a maintenance mode in the inhibited position. In particular, the locking device comprises a rocker to maintain the cowl to the pylon, and the rocker includes an inhibiting lever and an activation lever. The inhibiting and activation levers are mounted on a switching shaft of the locking device. The inhibiting lever is set in rotation through an actuator, providing direct access from a bypass flow duct in the active position while the activation lever is set in rotation from the bypass duct in the inhibited position. | 10-15-2015 |
Remy Pujol, Florensac FR
Patent application number | Description | Published |
---|---|---|
20100173874 | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear - The invention features methods and devices for local delivery of agents that modify glutamate-mediated neurotransmission to the inner ear for treatment of inner ear disorders caused by glutamate-induced hearing loss and/or tinnitus. | 07-08-2010 |
Remy Pujol, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20100254907 | METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY - The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The tinnitus to be prevented and/or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method. | 10-07-2010 |
20140017172 | METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY - The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The tinnitus to be prevented and/or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method. | 01-16-2014 |
20150057360 | METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY - The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The tinnitus to be prevented and/or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method. | 02-26-2015 |
20150265552 | METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY - The invention relates to methods for the prevention and/or treatment of tinnitus induced by cochlear excitotoxicity. In these methods, a pharmaceutical composition comprising an NMDA receptor antagonist is administered to an individual in need of such treatment by appropriate devices and/or formulations for local administration to the inner ear. The tinnitus to be prevented and/or treated may be provoked by acoustic trauma, presbycusis, ischemia, anoxia, treatment with one or more ototoxic medications, sudden deafness, or other cochlear excitotoxic-inducing occurrence. The invention also relates to method for the identification of compounds effective in the treatment and prevention of tinnitus by a novel screening method incorporating an electrophysiological test method. | 09-24-2015 |
Robert Pujol, Teyran FR
Patent application number | Description | Published |
---|---|---|
20120267457 | METHOD AND DEVICE HAVING A SIMPLIFIED CONSTRUCTIONS FOR THE REFERENCE GRINDING OF WHEAT - A process for simplified production of a reference milling for determining the milling quality of wheat, includes: a first crushing of a wheat sample; a first sieving of the crushed product into three distinct levels of particle size; a second crushing of oversize particles resulting from the first crushing; a second sieving of the oversize particles thus crushed; a mixing of coarse semolina resulting from the sievings; a third crushing of the mixture of the coarse semolina; a third sieving of the mixture of the coarse semolina thus crushed into two distinct levels of particle size; a mixing of fine semolina resulting from each of the three sievings; a fourth crushing of the mixture of fine semolina; a fourth sieving of the mixture of the fine semolina thus crushed into a single level of particle size; a mixing of the flours resulting from sievings, the mixture constituting the desired milling. | 10-25-2012 |